» Articles » PMID: 35882216

First Trimester Dexamethasone Treatment Is Not Associated With Alteration in Resting-state Connectivity at Adolescent or Adult Age

Overview
Specialty Endocrinology
Date 2022 Jul 26
PMID 35882216
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Prenatal treatment with dexamethasone (DEX) has been used to prevent virilization in females at risk of congenital adrenal hyperplasia (CAH). Both affected and unaffected girls, as well boys, are treated until the genotype and sex of the fetus is known (gestational weeks 10-12). After that, only affected girls are treated until term. Exposure to a high synthetic glucocorticoid dosage may alter the developmental trajectory of the brain, with alterations in resting-state functional connectivity of the brain at adult age.

Objective: To investigate resting-state functional connectivity in subjects at risk of having CAH, exposed to DEX treatment during the first trimester of fetal life, both in the whole brain and in 3 regions of interest (amygdala, hippocampus, and superior frontal gyrus).

Design, Setting, And Participants: Eighteen participants (8 females) at risk of having CAH, exposed to DEX treatment, and 38 controls (24 females), age range 16 to 26 years, from a single research institute, underwent functional magnetic resonance imaging of the brain during rest. We used 2 different approaches: an exploratory whole-brain analysis and seed-based analysis. For seed-based analysis, we chose 3 different brain regions (amygdala, hippocampus, and superior frontal gyrus) based on our previous findings and literature evidence.

Results: We did not observe any differences in functional connectivity during rest, either in the whole brain nor in seed-based connectivity analyses at this adolescent and young adult age.

Conclusions: Our results are reassuring; however, future studies on larger samples and with more sensitive methodologies are needed to confirm these findings.

Citing Articles

An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia.

Vant Westeinde A, Karlsson L, Messina V, Wallensteen L, Brosamle M, Dal Maso G Endocr Connect. 2023; 12(4).

PMID: 36752813 PMC: 10083667. DOI: 10.1530/EC-22-0400.

References
1.
Vant Westeinde A, Karlsson L, Nordenstrom A, Padilla N, Lajic S . First-Trimester Prenatal Dexamethasone Treatment Is Associated With Alterations in Brain Structure at Adult Age. J Clin Endocrinol Metab. 2020; 105(8). PMC: 7304558. DOI: 10.1210/clinem/dgaa340. View

2.
Anacker C, Cattaneo A, Musaelyan K, Zunszain P, Horowitz M, Molteni R . Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc Natl Acad Sci U S A. 2013; 110(21):8708-13. PMC: 3666742. DOI: 10.1073/pnas.1300886110. View

3.
Kim D, Davis E, Sandman C, Sporns O, ODonnell B, Buss C . Children's intellectual ability is associated with structural network integrity. Neuroimage. 2015; 124(Pt A):550-556. PMC: 4651770. DOI: 10.1016/j.neuroimage.2015.09.012. View

4.
Davis E, Sandman C, Buss C, Wing D, Head K . Fetal glucocorticoid exposure is associated with preadolescent brain development. Biol Psychiatry. 2013; 74(9):647-55. PMC: 3985475. DOI: 10.1016/j.biopsych.2013.03.009. View

5.
Pallant J, Bailey C . Assessment of the structure of the Hospital Anxiety and Depression Scale in musculoskeletal patients. Health Qual Life Outcomes. 2005; 3:82. PMC: 1343593. DOI: 10.1186/1477-7525-3-82. View